Project Number GC-2013061 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for GABA-A alpha-5 Positive Allosteric Modulators for the treatment of aMCI due to AD. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AgeneBio Inc Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $750,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
